Hepatitis B Virus Core Protein Mediates the Upregulation of C5? Receptor 1 via NF-KB Pathway to Facilitate the Growth and Migration of Hepatoma Cells

被引:0
作者
Kong, Fanyun [1 ]
Tao, Yukai [1 ,2 ]
Yuan, Dongchen [1 ]
Zhang, Ning [1 ]
Li, Qi [1 ]
Yu, Tong [1 ]
Yang, Xiaoying [1 ]
Kong, Delong [1 ]
Ding, Xiaohui [1 ]
Liu, Xiangye [1 ]
You, Hongjuan [1 ]
Zheng, Kuiyang [1 ,3 ]
Tang, Renxian [1 ,3 ]
机构
[1] Xuzhou Med Univ, Dept Pathogen Biol & Immunol, Jiangsu Key Lab Immun & Metab, Xuzhou 221004, Jiangsu, Peoples R China
[2] First Peoples Hosp Kunshan, Clin Res & Lab Ctr, Kunshan, Peoples R China
[3] Xuzhou Med Univ, Natl Demonstrat Ctr Expt Basic Med Sci Educ, Xuzhou, Jiangsu, Peoples R China
来源
CANCER RESEARCH AND TREATMENT | 2021年 / 53卷 / 02期
基金
中国国家自然科学基金;
关键词
Hepatitis B virus; HBc; C5?R1; Hepatocellular carcinoma; Growth; Migration; CANCER; EXPRESSION;
D O I
10.4143/crt.2020.397CancerResTreat.2021;53
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose C5 alpha receptor 1 (C5 alpha R1) is associated with the development of various human cancers. However, whether it is involved in the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is poorly understood. We explored the expression, biological role, and associated mechanisms of C5AR1 in HBV-related hepatoma cells. Materials and Methods The expression of C5 alpha R1 mediated by HBV and HBV core protein (HBc) was detected in hepatoma cells. The function of nuclear factor ?B (NF-kappa B) pathway in HBc-induced C5AR1 expression was assessed. The roles of C5 alpha R1 in the activation of intracellular signal pathways, the upregulation of inflammatory cytokines, and the growth and migration of hepatoma cells mediated by HBc, were investigated. The effect of C5 alpha in the development of HCC mediated by C5AR1 was also measured. Results C5 alpha R1 expression was increased in HBV-positive hepatoma cells. Dependent on HBc, HBV enhanced the expression of C5 alpha R1 at the mRNA and protein levels. Besides, HBc could promote C5 alpha R1 expression via the NF-kappa B pathway. Based on the C5 alpha R1, HBc facilitated the activation of JNK and ERK pathways and the expression and secretion of interleukin-6 in hepatoma cells. Further- more, C5 alpha R1 was responsible for enhancing the growth and migration of hepatoma cells mediated by HBc. Except these, C5 alpha could promote the malignant development of HBc-positive HCC via C5AR1. Conclusion We provide new insight into the mechanisms of hepatocarcinogenesis mediated by HBc. C5 alpha R1 has a significant role in the functional abnormality of hepatoma cells mediated by HBc, and might be utilized as a potential therapeutic target for HBV-related HCC.
引用
收藏
页码:506 / 527
页数:22
相关论文
共 36 条
[1]   Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects [J].
Ajona, Daniel ;
Zandueta, Carolina ;
Corrales, Leticia ;
Moreno, Haritz ;
Pajares, Maria J. ;
Ortiz-Espinosa, Sergio ;
Martinez-Terroba, Elena ;
Perurena, Naiara ;
de Miguel, Fernando J. ;
Jantus-Lewintre, Eloisa ;
Camps, Carlos ;
Vicent, Silvestre ;
Agorreta, Jackeline ;
Montuenga, Luis M. ;
Pio, Ruben ;
Lecanda, Fernando .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (09) :1164-1176
[2]   The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury [J].
Brandolini, Laura ;
Grannonico, Marta ;
Bianchini, Gianluca ;
Colanardi, Alessia ;
Sebastiani, Pierluigi ;
Paladini, Antonella ;
Piroli, Alba ;
Allegretti, Marcello ;
Varrassi, Giustino ;
Di Loreto, Silvia .
NEUROTOXICITY RESEARCH, 2019, 36 (01) :163-174
[3]   Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression [J].
Chen, Jian ;
Li, Gui-qing ;
Zhang, Li ;
Tang, Ming ;
Cao, Xu ;
Xu, Gui-lian ;
Wu, Yu-Zhang .
CANCER LETTERS, 2018, 412 :30-36
[4]   The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals [J].
Diab, Ahmed ;
Foca, Adrien ;
Zoulim, Fabien ;
Durantel, David ;
Andrisani, Ourania .
ANTIVIRAL RESEARCH, 2018, 149 :211-220
[5]   Hepatitis B core protein promotes liver cancer metastasis through miR-382-5p/DLC-1 axis [J].
Du, Juan ;
Bai, Fuxiang ;
Zhao, Peiqing ;
Li, Xiaoyan ;
Li, Xueen ;
Gao, Lifen ;
Ma, Chunhong ;
Liang, Xiaohong .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2018, 1865 (01) :1-11
[6]   Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner [J].
Gai, Xiaoxiao ;
Zhao, Peiqing ;
Pan, Yingfang ;
Shan, Haixia ;
Yue, Xuetian ;
Du, Juan ;
Zhang, Zhenyu ;
Liu, Peng ;
Ma, Hongxin ;
Guo, Min ;
Yang, Xiaoyun ;
Sun, Wensheng ;
Gao, Lifen ;
Ma, Chunhong ;
Liang, Xiaohong .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2013, 45 (07) :1174-1185
[7]   Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer [J].
Gu, Jie ;
Ding, Jian-yong ;
Lu, Chun-lai ;
Lin, Zong-wu ;
Chu, Yi-wei ;
Zhao, Guang-yin ;
Guo, Jing ;
Ge, Di .
LUNG CANCER, 2013, 81 (02) :259-265
[8]   C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition [J].
Hu, Wen-Hao ;
Hu, Zhe ;
Shen, Xian ;
Dong, Li -Yang ;
Zhou, Wei-Zhong ;
Yu, Xi -Xiang .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2016, 100 (01) :101-108
[9]   Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma [J].
Jekarl, Dong Wook ;
Lee, Seungok ;
Kwon, Jung Hyun ;
Nam, Soon Woo ;
Kim, Myungshin ;
Kim, Yonggoo ;
Jang, Jeong Won .
PLOS ONE, 2019, 14 (11)
[10]   C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA [J].
Kaida, Takayoshi ;
Nitta, Hidetoshi ;
Kitano, Yuki ;
Yamamura, Kensuke ;
Arima, Kota ;
Izumi, Daisuke ;
Higashi, Takaaki ;
Kurashige, Junji ;
Imai, Katsunori ;
Hayashi, Hiromitsu ;
Iwatsuki, Masaaki ;
Ishimoto, Takatsugu ;
Hashimoto, Daisuke ;
Yamashita, Yoichi ;
Chikamoto, Akira ;
Imamura, Takahisa ;
Ishiko, Takatoshi ;
Beppu, Toru ;
Baba, Hideo .
ONCOTARGET, 2016, 7 (51) :84798-84809